Company Profile

DanDrit Biotech USA is a US based clinical-stage oncology company developing new approaches to leverage the immune system to fight cancers and infectious diseases. Our vision is to radically improve outcomes for patients with unmet needs in HIV/AIDS and oncology. Our intent is to develop transformative, multi-indication, platform drugs that harness the power of immunotherapy and change the standards of care of AIDS and cancer. We will expedite programs to market through strategic development and leveraging enhanced FDA programs and corporate partnerships.